Kevin R. Sayer

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Guardant Health, Inc. publishes a filing, an earnings call transcript or a press release.

Get GH alerts

About Kevin R. Sayer

Kevin R. Sayer is recorded as Board Member at Guardant Health, Inc. (GH) since November 2, 2026. Guardant Health, Inc. reported in an 8-K filed November 3, 2026 that Kevin R. Sayer was appointed Class II director, effective November 2, 2026. Guardant Health, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Guardant Health, Inc. includes AmirAli Talasaz (CEO and Board Member), Helmy Eltoukhy (CEO, Chairman and Board Member), Michael Bell (CFO) and 7 others.

“On November 2, 2026, the Board of Directors (the “Board”) of Guardant Health, Inc. (the “Company”) increased the number of directors on the Board to 11 and appointed Kevin R. Sayer, 68, as a Class II director of the Company, to be effective as of November 2, 2026.”

Guardant Health, Inc. Form 8-K, filed November 3, 2026 · Read the filing

Affiliation history

Guardant Health, Inc. (GH)
Board Member

SEC 8-K

Current
2026-11-02–present

Company network

Guardant Health, Inc.

Current role

Diagnostics & Research · Healthcare

Board Member

2026-11-02–present

Leadership on record at Guardant Health, Inc.

AmirAli Talasaz CEO, Board Member
Helmy Eltoukhy CEO, Chairman, Board Member
Michael Bell CFO
Ines Dahne-Steuber COO
Darya Chudova CTO
Kumud Kalia CIO
John Saia General Counsel
Robert A. Parks Chief Accounting Officer
Alex M. Azar II Board Member
Ian Clark Board Member

Recent activity

Executive change Appointed: Class II director Guardant Health, Inc. (GH)
2026-11-02